The Japanese Biochemical Society

[1T14e-11(P-800)] The SGLT2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model

Naoki Yoshioka1,2, Miyako Tanaka1, Kozue Ochi1, Akiko Watanabe1, Michiko Itoh3,4, Masatoshi Ishigami2, Mitsuhiro Fujishiro2, Takayoshi Suganami1 (1.Department of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, 2.Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 3.Kanagawa Institute of Industrial Science and Technology, 4.Department of Metabolic Syndrome and Nutritional Science, Research Institute of Environmental Medicine, Nagoya University)

The 94th Annual Meeting of JBS |Wed. Nov 3, 2021 6:40 PM - 6:50 PM

[1T15e-01(P-946)] Novel aminocyclopropenone compound inhibits BRD4-driven NUP210 expression and attenuates cancer growth

Hiroya Kondo1, Kenji Mishiro2, Masaharu Hazawa2,3,4, Yuki Iwashima4, Akiko Kobayashi2, Kazuma Ogawa2, Wong Richard2,3,4 (1.Division of Transdisciplinary Sciences, Institute for Frontier Science Initiative, Kanazawa Univ., Japan, 2.Institute for Frontier Science Initiative, Kanazawa Univ., Japan, 3.WPI Nano Life Science Institute, Kanazawa univ., Japan, 4.Division of Life Science and Engineering, Institute for Science and Engineering, Kanazawa Univ., Japan)

The 94th Annual Meeting of JBS |Wed. Nov 3, 2021 5:00 PM - 5:10 PM

[1T15e-03(P-939)] A novel tetravalent peptide directly binds to APP to inhibit the production of Amyloid β in cells.

Waka Sato1, Miho Takahashi1, Hina Uchiyama2, Takashi Saito3, Takaomi Saido4, Satoru Funamoto2, Kiyotaka Nishikawa1 (1.Doshisha University, Grad. School of Life and Medical Sciences, Molecular Life Sciences, 2.Doshisha University, Grad. School of Life and Medical Sciences, Neuropathology, 3.Nagoya City University, Grad.School of Medical Science, Department of Neurocognitive Science, 4.Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science)

The 94th Annual Meeting of JBS |Wed. Nov 3, 2021 5:20 PM - 5:30 PM

[1T15e-07(P-975)] Cell membrane-penetrating sequence of saporin toxin and its application for drug delivery system

Momoko Obuki1, Miku Katayama1, Kosuke Noguchi1, Stefania Zuppone2, Mayu Yamana3, Tomoka Takatani-Nakase4,5, Masashi Ueda3,6, Riccardo Vago2,7, Shiroh Futaki8, Arwyn T. Jones9, Ikuhiko Nakase1 (1.Graduate School of Science, Osaka Prefecture University, 2.IRCCS San Raffaele Hospital, 3.College of Pharmacy, Okayama University, 4.College of Pharmacy, Mukogawa Women University, 5.Institute for Biosciences, Mukogawa Women University, 6.Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, 7.University Vita-Salute San Raffaele, 8.Institute for Chemical Research, Kyoto University, 9.School of Pharmacy and Pharmaceutical Sciences, Cardiff University)

The 94th Annual Meeting of JBS |Wed. Nov 3, 2021 6:00 PM - 6:10 PM

[1T15e-09(P-957)] Development of a core fucose-deficient cancer-specific anti-podocalyxin antibody (60-mG2a-f) for pancreatic carcinoma

Mika K. Kaneko1, Tomokazu Ohishi2, Manabu Kawada2, Yukinari Kato1,3 (1.Dept. Antibody Drug Development, Tohoku University Grad. Sch. of Med., 2.Inst. of Microbial Chemistry (BIKAKEN), Numazu, Microbial Chemistry Res. Foundation, 3.Dept. Molecular Pharmacology, Tohoku University Grad. Sch. of Med.)

The 94th Annual Meeting of JBS |Wed. Nov 3, 2021 6:20 PM - 6:30 PM